Treatment will depend on your age, overall health, and the severity of your symptoms. BPH symptoms may come and go, so it’s important to receive regular check-ups to monitor the progression of symptoms. There are many ways to successfully treat BPH, including some simple lifestyle changes if your symptoms are mild and several herbal remedies and medications that can be effective. If no other therapies work and the symptoms are severe enough, there are also several types of surgery to correct the condition.
Lifestyle
Many men with BPH have only minor symptoms. Some simple lifestyle changes may be all you need to feel better:
- Urinate when you first get the urge.
- Go to the bathroom when you have the chance, even if you don't feel a need to urinate.
- Avoid alcohol and caffeine, especially after dinner. Try not to drink within 2 hours before going to bed.
- Spread out your fluid intake throughout the day -- avoid drinking large amounts of fluid at one time.
- Avoid cold and sinus medications. Decongestants and antihistamines can worsen BPH symptoms.
- Exercise regularly.
- Do Kegel exercises to strengthen your pelvic floor.
- Reduce stress.
Medications
Alpha blockers -- cause the muscles around your bladder to relax, making it easier to urinate. These drugs were originally used to treat high blood pressure, and seem to work best in men with moderately enlarged prostates. Common side effects include decreased ejaculation and low blood pressure. These drugs should not be taken with medications for erectile dysfunction, such as Viagra or Cialis. Alpha blockers include:
- Terzosin (Hytrin)
- Doxazosin (Cardura)
- Tamsulosin (Flomax)
- Alfuzosin (Uroxatral)
5-alpha-reductase inhibitors -- shrink the prostate gland by lowering the amount of testosterone that the body converts into dihydrotestosterone, a hormone the prostate needs to grow. These drugs take longer to work than alpha blockers, and they lower PSA levels (a high level of PSA can indicate prostate cancer), making it harder to screen for prostate cancer. Enzyme inhibitors include:
- Finasteride (Proscar)
- Dutasteride (Avodart)
- Botulinum Toxin - Recent studies suggest that most patients with BPH experience symptomatic improvement from injections of botulinum toxin into the prostate.
Your doctor may suggest combination therapy -- taking an alpha blocker and an enzyme inhibitor at the same time.
Surgery and Other Procedures
Prostate surgery may be recommended if you have:
- Incontinence
- Recurrent blood in the urine
- Urinary retention
- Recurrent urinary tract infections
Which procedure is best for you usually depends on the severity of your symptoms and the size and shape of your prostate gland.
Minimally invasive techniques
These techniques may be better at relieving symptoms than medications, but are often not as effective as surgery. However, they are less likely to cause side effects than surgery.
Transurethtral microwave therapy -- uses heat from microwaves to shrink the prostate. This procedure works best for men with moderate symptoms and enlargement of the prostate.
Transurethral needle ablation -- uses radio waves to get rid of the part of the prostate that is blocking urine flow. It works best for men with mild to moderate enlargement of the prostate.
Interstitial laser therapy -- uses a laser to destroy excess tissue and shrink the prostate. It works best for men who have mild to moderate enlargement of the prostate and don’t experience urinary retention.
Surgery
Surgery is the most effective way to reduce your symptoms, but potential side effects include a small risk of erectile dysfunction or urinary incontinence.
Transurethral resection of the prostate (TURP) -- is the most common surgical treatment for BPH. It is performed by inserting a scope through the penis and removing the interior of the prostate piece by piece. It reduces symptoms quickly and is often used to treat men with moderately or severely enlarged prostates. One potential side effect is retrograde ejaculation, where semen goes into the bladder instead of out the urethra.
Transurethral incision of the prostate (TUIP) -- similar to TURP, but is usually performed in men who have a relatively small prostate. Like the TURP, a scope is inserted through the penis until the prostate is reached. Then, rather than removing prostate tissue, a small incision is made in the tissue to let the urethra expand and make urination easier.
Laser surgery -- Two types of laser surgery are used to destroy excess prostate tissue. Photosensitive vaporization of the prostate (PVP) is used for men with mild to moderate prostate enlargement, while holmium laser enucleation of the prostate (HoLEP) is usually used for men with severely enlarged prostates. Side effects can include retrograde ejaculation.
Open prostatectomy -- usually performed using general or spinal anesthesia. A surgeon makes an incision in your lower abdomen to reach the prostate and removes the inner part of the gland. This is a lengthy procedure, and usually requires a hospital stay of 5 - 10 days.
Most men who have prostate surgery see improvement in urine flow rates and symptoms. Possible complications include impotence, urinary incontinence, retrograde ejaculation, infertility, and urethral stricture (narrowing).
Nutrition and Dietary Supplements
Beta-sitosterol (60 - 130 mg per day) -- Beta-sitosterol is a cholesterol like compound found in plants. It has been studied for BPH and found to significantly improve urinary flow and decrease the amount of urine left in the bladder. It does not shrink the prostate, however. Beta-sitosterol is also used to lower cholesterol, making it a good option for men whose cholesterol levels are high. Plants that are high in beta-sitosterol, such as pumpkin seeds (Cucurbita pepo), are sometimes suggested for BPH. Talk to your doctor before adding any supplements to your BPH treatment regimen.
Herbs
The use of herbs is a time honored approach to strengthening the body and treating disease. Herbs, however, can trigger side effects and can interact with other herbs, supplements, or medications. For these reasons, you should take herbs with care, under the supervision of a health care practitioner.
- Saw palmetto (Serenoa repens, 320 mg per day) -- A number of studies have examined whether saw palmetto can relieve BPH symptoms, and many (though not all) showed positive results. Saw palmetto appears to work like Proscar and Avodart, which prevent testosterone from being converted into dihydrotestosterone (needed for prostate growth) in the body. Some studies have shown saw palmetto to be as effective as Proscar and finasteride and with fewer side effects. A European study showed that half of German urologists preferred saw palmetto over pharma agents for treatment of BPH. However, it does not shrink the overall prostate, but shrinks the inner lining of the gland. It should be noted that, unlike previous studies, a newer, high quality study found that saw palmetto had no effect on BPH symptoms. Talk to your doctor if you want to try saw palmetto for your symptoms, and look for a fat soluble saw palmetto extract that has been standardized to contain 85% - 95% fatty acids and sterols.
- Pygeum or African plum extract (Pygeum africanum, 75 - 200 mg per day) -- Pygeum has been used historically for urinary problems. In several scientific studies, pygeum relieved BPH symptoms including nocturia (increased urination at night) and improved urine flow.
- Grass pollen (Secale cereale) -- Two studies that compared a standardized extract of rye grass pollen to placebo found that the grass pollen improved BPH symptoms, including reducing frequency of nighttime urination and the amount of urine left in the bladder. One study also indicated that grass pollen decreased the size of the prostate as measured by ultrasound. The brand of rye grass pollen most often used in studies is Cernilton. People who have allergies to grass pollens should not take grass pollen supplements.
|  |
Prognosis and Complications
While the majority of men get better with treatment of BPH, men who have had long standing BPH may develop:
- Sudden inability to urinate
- Urinary tract infections
- Urinary stones
- Damage to the kidneys
- Blood in the urine
Berges RR, Kassen A, Senge T. Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. BJU Int. 2000;85:842-6.
Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet. 1995;345:1529-32.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, Mass: Integrative Medicine Communications; 1998:201.
Bondarenko B, Walther C, Funk P, Schlafke S, Engelmann U. Long-term efficacy and safety of PRO 160/120 (a combination of sabal and urtica extract) in patients with lower urinary tract symptoms (LUTS). Phytomedicine. 2003:10 Suppl 4:53-55.
Boy S, Seif C, Braun PM, Junemann KP. Botulinum toxin in the treatment of benign prostatic hyperplasia: an overview. Urologe A. 2008;47(11):1465-71.
Braeckman J. The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study. Curr Therapeut Res. 1994;55:776–785.
Buck AC, Cox R, Rees RW, et al. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. Br J Urol. 1990;66:398-404.
Chapple CR. Clinical study of benign prostatic disease, current concepts and future prospects randomized controlled trials versus real life practice. Curr Opin Urol. 2003;13(1):1-5.
Delongchamps N, de la Roza G, Chandan V, Jones R, Sunheimer R, Threatte G, Jumbelic M, Haas GP. Evaluation of prostatitis in autopsied prostates -- is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol. 2008;179(5):1736-40.
Denis L, Morton MS, Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol. 1999;35(5-6):377-387.
Di Silverio F, D'Eramo G, Lubrano C, et al. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Uro. 1992;21:309-314.
Edwards J. Diagnosis and Management of Benign Prostatic Hyperplasia. American Family Physician. 2008;77(10).
Ernst E. Herbal medications for common ailments in the elderly. Drugs Aging. 1999;15(6):423-428.
Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002;136(1):42-53.
Ferri: Ferri's Clinical Advisor 2010, 1st ed. Philadelphia, PA: Mosby Elsevier, Inc. 2009.
Gerber GS. Saw palmetto for the treatment of men with lower urinary tract symptoms. J Urol. 2000;163(5):1408-1412.
Gerber GS, Kuznetsov D, Johnson BC, Burstein JD. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology. 2001;58(6):960-965.
Goepel M, Hecker U, Krege S. Saw palmetto extracts potently and noncompetitively inhibit human a1-adrenoceptors in vitro. Prostate. 1998;38(3):208–215.
Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Am Fam Physician. 2003;67(6):1281-1283.
Ishani A, MacDonald R, Nelson D, et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med. 2000;109:654-64.
Katz AE. Flavonoid and botanical approaches to prostate health. J Altern Complemet Med. 2002;8(6):813-821.
Klingler HC. New innovative therapies for benign prostatic hyperplasia: any advance? Curr Opin Urol. 2003;13(1):11-15.
Koch E. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Planta Med. 2001;67(6):489-500.
Krzeski T, Kazon M, Borkowski A, Witeska A, Kuczera J. Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses. Clin Ther. 1993;15:1011–1020.
Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO, Trichopoulos D. Diet and benign prostatic hyperplasia: a study in Greece. Urology. 1999;54(2):284-290.
MacDonald R, Ishani A, Rutks I, Wilt TJ. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int. 2000;85:836-41.
Managing lower urinary tract symptoms in men. Drug Ther Bull. 2003;41(3):18-21.
Marks LS, Partin AW, Epstein JI, et al. Effects of saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol. 2000;163(5):1451-1456.
Nichol MB, Knight TK, Wu J, Barron R, Penson DF. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia. J Urol. 2009;181(5):2214-21.
Pittler MH. Complementary therapies for treating benign prostatic hyperplasia. FACT. 2000;5(4):255-257.
Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Philadelphia, Penn: Hanley & Belfus, Inc.; 2002:327-331.
Shi R, Xie Q, Gang X, Lun J, Cheng L, Pantuck A, Rao J. Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China. J Urol. 2008;179(2):610-5.
Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr. 2002;75(4):689-697.
Willets KE, Clements MS, Champion S, Ehsman S, Eden JA. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial. BJU Int. 2003;92(3):267-270.
Wilt T, Ishani A, Mac Donald R, et al. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002;CD001044.
Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002;(3):CD001423
Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr. 2000;3(4A):459-472.
Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systemic review. JAMA. 1998;280(18):1604-1609.
